These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37292835)

  • 1. Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification.
    Peretz CAC; Kennedy VE; Walia A; Delley CL; Koh A; Tran E; Clark IC; Hayford CE; D'Amato C; Xue Y; Fontanez KM; Roy R; Logan AC; Perl AE; Abate A; Olshen A; Smith CC
    bioRxiv; 2023 May; ():. PubMed ID: 37292835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
    Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
    Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
    Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
    Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
    Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
    Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
    Khan M; Siddiqi R; Naqvi K
    Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.
    Chang TY; Chen SH; Jaing TH; Yang SH; Wen YC; Yang CP; Hung IJ
    Pediatr Neonatol; 2021 Jan; 62(1):21-25. PubMed ID: 32859541
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
    Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes.
    Eckstein OS; Wang L; Punia JN; Kornblau SM; Andreeff M; Wheeler DA; Goodell MA; Rau RE
    Exp Hematol; 2016 Aug; 44(8):740-4. PubMed ID: 27208809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia with mixed phenotype is characterized by stemness transcriptomic signatures and limited lineage plasticity.
    Galera P; Dilip D; Derkach A; Chan A; Zhang Y; Persuad S; Mishera T; Liu Y; Famulare C; Gao Q; Mata DA; Arcila M; Geyer MB; Stein E; Dogan A; Levine RL; Roshal M; Glass J; Xiao W
    medRxiv; 2023 Nov; ():. PubMed ID: 37961275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
    Shiozawa Y; Fujita S; Nannya Y; Ogawa S; Nomura N; Kiguchi T; Sezaki N; Kudo H; Toyama T
    Int J Hematol; 2024 Apr; 119(4):465-471. PubMed ID: 38424413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
    Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
    Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genomic and biological complexity of mixed phenotype acute leukemia.
    Andrews C; Tierens A; Minden M
    Crit Rev Clin Lab Sci; 2021 May; 58(3):153-166. PubMed ID: 33161794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL
    Weinberg OK; Dennis J; Zia H; Chen P; Chu A; Koduru P; Luu HS; Fuda F; Chen W
    Int J Lab Hematol; 2023 Apr; 45(2):170-178. PubMed ID: 36325594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed phenotype acute leukemia.
    Ye Z; Wang S
    Chin Med J (Engl); 2014; 127(16):2999-3003. PubMed ID: 25131241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.
    Tan K; Xu J; Chen C; Vincent T; Pölönen P; Hu J; Yoshimura S; Yu W; Sussman J; Chen CH; Li E; Diorio C; Shraim R; Newman H; Uppuluri L; Li A; Chen G; Bandyopadhyay S; Wu D; Ding YY; Xu J; Lim T; Hsu M; Thadi A; Ahn KJ; Wu CY; Peng J; Sun Y; Wang A; Mehta R; Frank D; Meyer L; Loh M; Raetz E; Chen Z; Wood B; Devidas M; Dunsmore K; Winter S; Chang TC; Wu G; Pounds S; Zhang N; Carroll W; Hunger S; Bernt K; Yang J; Mullighan C; Teachey D
    Res Sq; 2023 Oct; ():. PubMed ID: 37961674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.